Akorn Inc.

Warning LetterClosed

United StatesFEI 3003102962Issued Jun 13, 2019

Source: FDA warning letter records. FDA has not published the text of this letter. To check it, open FDA's record for this establishment, listed under FEI 3003102962.

Letter Details

Firm: Akorn Inc.
Location: United States
FEI Number: 3003102962
Country: United States
Issue Date: June 13, 2019
Issuing Office: N/A
Product Type: Drugs
Status: Closed

Summary

Based on limited metadata, Akorn Inc. received an FDA Warning Letter in June 2019 regarding drug manufacturing or quality control issues, though the specific violations cannot be detailed without access to the full letter text. The warning falls under FDA's drug product regulatory jurisdiction, indicating concerns likely related to manufacturing practices, product quality, or compliance with pharmaceutical regulations. Without the complete letter subject line and violation details, the precise nature of the compliance failures cannot be specified beyond confirming they involve the company's drug products or operations.